These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

601 related items for PubMed ID: 26986147

  • 1. Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients.
    Lee H, Min JW, Kim JI, Moon IS, Park KH, Yang CW, Chung BH, Oh EJ.
    Medicine (Baltimore); 2016 Mar; 95(11):e3094. PubMed ID: 26986147
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant.
    Tagliamacco A, Cioni M, Comoli P, Ramondetta M, Brambilla C, Trivelli A, Magnasco A, Biticchi R, Fontana I, Dulbecco P, Palombo D, Klersy C, Ghiggeri GM, Ginevri F, Cardillo M, Nocera A.
    Transpl Int; 2014 Jul; 27(7):667-73. PubMed ID: 24629017
    [Abstract] [Full Text] [Related]

  • 5. De novo donor specific antibodies and patient outcomes in renal transplantation.
    DeVos JM, Patel SJ, Burns KM, Dilioglou S, Gaber LW, Knight RJ, Gaber AO, Land GA.
    Clin Transpl; 2011 Jul; ():351-8. PubMed ID: 22755430
    [Abstract] [Full Text] [Related]

  • 6. Targeted monitoring of donor-specific HLA antibodies following renal transplantation.
    Almeshari K, Pall A, Chaballout A, Elgamal H, Almana H, Alzayer F, Abaalkhail N, Altalhi M.
    Clin Transpl; 2011 Jul; ():395-400. PubMed ID: 22755437
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D, Lee J, Schwartz JE, Friedlander R, Aull M, Muthukumar T, Campbell S, Epstein D, Seshan SV, Kapur S, Sharma VK, Suthanthiran M, Dadhania D.
    Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation.
    Malheiro J, Tafulo S, Dias L, Martins LS, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A.
    Transpl Immunol; 2015 Mar; 32(2):66-71. PubMed ID: 25661873
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.
    Lobo LJ, Aris RM, Schmitz J, Neuringer IP.
    J Heart Lung Transplant; 2013 Jan; 32(1):70-7. PubMed ID: 23260706
    [Abstract] [Full Text] [Related]

  • 14. Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss.
    Fidler S, Swaminathan R, Lim W, Ferrari P, Witt C, Christiansen FT, D'Orsogna LJ, Irish AB.
    Transpl Immunol; 2013 Dec; 29(1-4):22-7. PubMed ID: 24090807
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Graft Immunocomplex Capture Fluorescence Analysis to Detect Donor-Specific Antibodies and HLA Antigen Complexes in the Allograft.
    Nakamura T, Ushigome H, Watabe K, Imanishi Y, Masuda K, Matsuyama T, Harada S, Koshino K, Iida T, Nobori S, Yoshimura N.
    Immunol Invest; 2017 Apr; 46(3):295-304. PubMed ID: 28151033
    [Abstract] [Full Text] [Related]

  • 17. Sialylation of antibodies in kidney recipients with de novo donor specific antibody, with or without antibody mediated rejection.
    Malard-Castagnet S, Dugast E, Degauque N, Pallier A, Soulillou JP, Cesbron A, Giral M, Harb J, Brouard S.
    Hum Immunol; 2016 Nov; 77(11):1076-1083. PubMed ID: 26546874
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival.
    Ho EK, Vlad G, Vasilescu ER, de la Torre L, Colovai AI, Burke E, Deng M, Schwartz J, Marboe C, Mancini D, Opelz G, Suciu-Foca N.
    Hum Immunol; 2011 Jan; 72(1):5-10. PubMed ID: 20971146
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.